Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation.
- 1 April 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 75 (4) , 888-893
- https://doi.org/10.1161/01.cir.75.4.888
Abstract
Cardiac electrophysiologic effects of verapamil in vivo are the result of both direct and indirect actions on the heart (the latter due to augmentation of sympathetic neural tone, diminution of parasympathetic neural tone, and increased circulating catecholamines). In this study we assessed the interaction of verapamil's direct and indirect actions on electrophysiologic properties of the heart in awake, previously instrumented, unsedated dogs. After administration of intravenous verapamil (0.2 mg/kg), electrophysiologic effects were assessed serially over a 1 hr period in 10 awake dogs before (group 1 studies) and during pharmacologic autonomic blockade (group 2 studies), and in a subset of these dogs (n = 5) after orthotopic cardiac transplantation (group 3 studies). In group 1 dogs, sinus cycle length (SCL) initially shortened after verapamil (postverapamil 379 +/- 50 msec vs baseline of 494 +/- 72 msec, p less than .001) and subsequently gradually prolonged. In groups 2 and 3, transient SCL shortening was absent. SCL prolonged promptly after verapamil, and sinus arrest developed in two of 10 group 2 and two of five group 3 animals. Verapamil exerted a negative dromotropic effect on atrioventricular node conduction in all three experimental groups, as assessed by drug-induced changes in minimum cycle length with sustained 1:1 atrioventricular conduction and measurements of atrioventricular node effective and functional refractory period. However, compared with findings in group 1, this negative dromotropic effect occurred more rapidly and was markedly potentiated in groups 2 and 3.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 23 references indexed in Scilit:
- Verapamil in chronic atrial fibrillation: Variable patterns of response in ventricular rateClinical Cardiology, 1984
- Combined verapamil and propranolol for supraventricular tachycardiaThe American Journal of Cardiology, 1984
- Long-term oral treatment with high doses of verapamil in lone atrial fibrillationClinical Cardiology, 1984
- Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A reviewThe American Journal of Cardiology, 1982
- Changes in cardiovascular function induced by verapamil in healthy subjects and in patients with ischemic heart diseaseClinical Cardiology, 1981
- Effects of intravenous verapamil on hemodynamics in patients with heart diseaseAmerican Heart Journal, 1977
- Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.Heart, 1977
- Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conductionCardiovascular Research, 1976
- Effects of Verapamil on the Blood-Perfused, Isolated Atrium Preparation of the Dog HeartJapanese Heart Journal, 1975
- Asystole after verapamil.BMJ, 1972